EDUCATION

Hodgkin's Lymphoma is a rare cancer of the lymphatic system. It comprises less than 1% of all cancers. About half of the patients with Hodgkin's express proteins associated with the Epstein-Barr virus (Mono). In most the cause is not known. It occurs more in men and mainly young adults. 1 in 100,000 people will be diagnosed. Survival rate has increased from 50% to 75-85% due to combination chemotheraphy and radiation treatments.

Classic Hodgkin's Disease is divided into four subtypes

1. Nodular sclerosis Hodgkin's Disease (NSHD) 60-75% of cases
2. Mixed Cellularity Hodgkin's Disease (MCHD) 5-15% of cases
3. Lymphocyte depletion Hodgkin's Disease (LDHD) 5-10% of cases
4. Lymphocyte rich classic Hodgkin's Disease (cLRHD) 5%(I HAVE)

Nodular Lymphocyte predominant Hodgkin's (nLPHD) 5% of cases

Diffuse Lymphocyte Predominant Hodgkin's (dLPHD) Rare

Staging

Stage I : HD involves one lymph node group or structure.

Stage II : HD involves two or more lymph node groups on same side of diaphragm or it involves
one lymph node group and involvement in one organ.

Stage III: involves lymph nodes on both sides of diaphragm or has moved to an organ or spleen.

Stage IV: Has spread through bloodstream to one or more organs or areas outside lymphatic
system.

A or B Can follow stage. Ex. Stage IIA or Stage IIB). A= no symptoms B= Symptoms present

Symptoms include

1. Swelling of lymph nodes
2. Fever
3. Night sweats
4. weight loss
5. fatigue
6. Itching

Treatment

1. Chemotherapy
2. Radiation
3. Stem Cell Transplant
4. Biological therapies
5. Surgery

This is basic generic information for more detailed visit a lymphoma site.